Pregnancy in women with hypertrophic cardiomyopathy

Arend F L Schinkel1

  • 1From the Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.

Cardiology in Review
|August 6, 2014
PubMed

Insights

Pregnancy in women with hypertrophic cardiomyopathy (HCM) has low maternal mortality (0.5%). Most pregnancies are uneventful, but risks like premature birth (26%) are increased for both mother and fetus.

Area of Science:

  • Cardiology
  • Maternal-Fetal Medicine
  • Genetics

Background:

  • Pregnancy significantly stresses the cardiovascular system.
  • Pre-existing heart conditions, like hypertrophic cardiomyopathy (HCM), increase risks during pregnancy.
  • Maternal mortality and adverse fetal outcomes are concerns in high-risk pregnancies.

Purpose of the Study:

  • To review maternal and fetal outcomes of pregnancy in women with hypertrophic cardiomyopathy (HCM).
  • To identify complications associated with pregnancy in HCM patients.
  • To provide an evidence-based overview for managing these pregnancies.

Main Methods:

  • Systematic literature review of MEDLINE database.
  • Inclusion of cohort design studies reporting pregnancy outcomes in HCM.
  • Pooled analysis of data from 11 studies (9 cohorts, 237 women, 408 pregnancies).

Main Results:

  • Most pregnancies in women with HCM were uneventful.
  • Maternal mortality rate was 0.5%, primarily in high-risk individuals.
  • Complications or symptom worsening occurred in 29% of patients.
  • Fetal risks included spontaneous abortion (15%), therapeutic abortion (5%), stillbirth (2%), and premature birth (26%).

Conclusions:

  • Pregnancy in women with HCM carries low maternal mortality, concentrated in high-risk profiles.
  • Fetal mortality rates are comparable to the general population.
  • Increased risk of premature birth is a significant concern in HCM pregnancies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
558
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
687
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
722
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
495